Clinical Conversations in Integrative Oncology: NDMAPS™ Product Insights

What began as a conversation between colleagues at the 2020 OncANP conference became the foundation for the NDMAPS initiative. Recognizing the growing need for evidence-informed tools to support clinicians caring for patients with a personal or family history of cancer, Drs Dugald Seely and Melanie Kusznireckyj identified a significant gap in clinically relevant integrative oncology products and resources. Driven by a shared commitment to advancing patient care, they combined their clinical expertise, naturopathic principles, and premium manufacturing to develop the NDMAPS product line, a practitioner-focused collection of evidence-informed formulations designed to support integrative oncology care and other complex conditions. This webinar explores the NDMAPS product portfolio, highlighting the scientific rationale, clinical applications, and practical indications for each formulation to help practitioners confidently integrate these products into oncology-focused clinical practice.

Learning Objectives

• Explain the NDMAPS product development and validation process, including the pre-launch clinical evaluation, evidence review, and practitioner feedback used to assess safety, tolerability, and clinical integration through case reporting
• Apply NDMAPS formulations to common integrative scenarios, including: supporting treatment-related fatigue and quality of life during and after chemotherapy; supporting immune health and inflammation; addressing treatment-induced peripheral neuropathy; and supporting survivorship, recurrence risk reduction, and long-term wellness following active treatment